Pashov Anastas, Monzavi-Karbassi Behjatolah, Raghava Gajendra, Kieber-Emmons Thomas
University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Crit Rev Immunol. 2007;27(3):247-70. doi: 10.1615/critrevimmunol.v27.i3.50.
Mechanisms of broad cross-protection, as seen in viral infection and also applied to vaccines, emphasize preexisting antibodies, CD8+ memory T cells, and accelerated B-cell responses reactive with conserved regions in antigens. Another practical application to induce broad-spectrum responses is making use of multispecific antigen recognition by antibodies and T cells. Antibody polyreactivity can be related to the capacity of the antigen-combining site to accommodate a number of different small epitopes or to attain different conformations. A better understanding of the functionality of molecular interactions with graded specificity might help the design of polyreactive immunogens inducing antibody responses to a predefined set of target antigens. We have found this approach useful in targeting tumor-associated carbohydrate antigens in cancer vaccine development. Using combinatorial libraries and pharmacophore design principles, carbohydrate mimetic peptides were created that not only induce antibodies with multiple specificities, but also cellular responses that inhibit tumor growth in vivo.
广泛交叉保护的机制,如在病毒感染中所见,也应用于疫苗,强调预先存在的抗体、CD8 + 记忆T细胞以及与抗原保守区域反应的加速B细胞反应。诱导广谱反应的另一个实际应用是利用抗体和T细胞的多特异性抗原识别。抗体的多反应性可能与抗原结合位点容纳多种不同小表位或获得不同构象的能力有关。更好地理解具有分级特异性的分子相互作用的功能,可能有助于设计能诱导针对预定义靶抗原组产生抗体反应的多反应性免疫原。我们发现这种方法在癌症疫苗开发中靶向肿瘤相关碳水化合物抗原方面很有用。利用组合文库和药效团设计原则,制备了碳水化合物模拟肽,其不仅能诱导具有多种特异性的抗体,还能诱导体内抑制肿瘤生长的细胞反应。